| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Quest Diagnostics Incorporated's insiders have reduced their positions by a net 32,677 shares worth roughly $7.9M.
Classified under Health Care Providers & Services (Health Care sector), DGX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 122.4K | $29.71M | - | |
| VP | 67.1K | $13.84M | - | |
| VP | 36.6K | $8.88M | - | |
| VP | 35.2K | $7.21M | - | |
| CFO | 33.6K | $7.92M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Davis J. E. | CEO and President | Sell | 10,000 | $242.72 | $2,427,200.00 | -7.6% | - | - | |
| Aug 28, 2026 | Prevoznik Michael E52 | SVP &General Counsel | Sale+OE | 22,677 | $243.11 | $5,513,082.84 | -37.6% | - | - | |
| Jul 28, 2026 | Delaney Mark E | SVP &Chief Commercial Officer | Sell | 1,600 | $235.18 | $376,288.00 | -13.4% | +2.5% | - | |
| Jun 4, 2026 | Kuppusamy Karthik | SVP, Clinical Solutions | Sale+OE | 8,147 | $200.00 | $1,629,400.00 | -37.6% | +22.8% | - | |
| Jun 1, 2026 | Davis J. E. | CEO and President | Sell | 10,000 | $194.14 | $1,941,400.00 | -7.0% | +25.0% | - | |
| Mar 5, 2026 | Plewman Patrick | SVP for Diagnostic Services | Sell | 2,855 | $206.21 | $588,729.55 | -15.8% | -5.1% | - | |
| Mar 5, 2026 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 3,878 | $206.21 | $799,682.38 | -9.4% | -5.1% | - | |
| Mar 5, 2026 | Doherty Catherine T.55 | EVP, Regional Businesses | Sell | 5,558 | $206.21 | $1,146,115.18 | -7.6% | -5.1% | - | |
| Mar 4, 2026 | Kuppusamy Karthik | SVP, Clinical Solutions | Sell | 2,628 | $204.86 | $538,372.08 | -16.4% | -7.3% | - | |
| Mar 3, 2026 | Plewman Patrick | SVP for Diagnostic Services | Sell | 410 | $207.73 | $85,169.30 | -2.6% | -7.8% | - |